-
How Covid-19 changed biotechnology – and how you can invest
Cover Story The pandemic has exacted a huge human and financial toll, but it has also transformed scientific research in ways that will deliver huge benefits for healthcare. Matthew Partridge reports.
Cover Story -
The best vaccine-makers’ stocks to buy now
Cover Story The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an eye on other products in their pipelines, says Dr Mike Tubbs.
Cover Story -
The huge potential of mRNA technology
Briefings The new technology made its name when it delivered Covid-19 vaccines in record time. But it could be pressed into use in many other areas too. Simon Wilson reports.
Briefings -
AstraZeneca’s Covid troubles could see it pull out of making vaccines
News AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
News -
A great leap forward in the war against Alzheimer’s disease
Cover Story The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs. That bodes well for Huntingdon’s and Parkinson’s sufferers too
Cover Story -
Why Joe Biden’s Big Pharma patent grab is a terrible idea
Briefings The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dangers for the future.
Briefings -
How to invest in the fight against Alzheimer’s disease
Cover Story The cost of caring for those with dementia is a growing problem for healthcare systems around the world. Any firm that develops an effective treatment could stand to make a fortune, reports Matthew Partridge.
Cover Story -
A show of support for GlaxoSmithKline's hedge fund fight
News Several large shareholders have said that they will support GlaxoSmithKline in its battle with hedge fund Elliott Management.
News -
How to invest in biotechnology: the healthcare sector’s high-growth area
Cover Story Dr Mike Tubbs provides an overview of this thriving industry, whose latest triumphs include the Covid-19 vaccines. He examines the best investment strategies and highlights his favourite picks.
Cover Story
